Back to Browse Journals » Journal of Pain Research » Volume 3

An open-label, non-randomized comparison of venlafaxine and gabapentin as monotherapy or adjuvant therapy in the management of neuropathic pain in patients with peripheral neuropathy

Authors William Eardley, Cory Toth

Published Date April 2010 Volume 2010:3 Pages 33—49

DOI http://dx.doi.org/10.2147/JPR.S8675

Published 1 April 2010

William Eardley, Cory Toth

Department of Clinical Neurosciences and the University of Calgary, Calgary, AB, Canada

Abstract: Although many therapies are used in the management of neuropathic pain (NeP) due to polyneuropathy (PN), few comparison studies exist. We performed a prospective, non-randomized, unblended, efficacy comparison of the serotonin-norepinephrine reuptake inhibitor venlafaxine, as either monotherapy or adjuvant therapy, with a first-line medication for NeP, gabapentin, in patients with PN-related NeP. VAS pain scores were assessed after 3 and 6 months in intervention groups and in a cohort of patients receiving no pharmacotherapy. In a total of 223 patients, we analyzed pain quantity and quality (visual analogue scale [VAS] score, Brief Pain Inventory [BPI]), quality of life and health status measures [EuroQol 5 Domains, EQ-5D], Medical Outcomes Sleep Study Scale [MOSSS], Hospital Anxiety and Depression Scale [HADS] and Short Form 36 Health Survey [SF-36]) after 6 months of therapy. Significant improvements in VAS pain scores occurred for all treatment groups after 6 months. Improvements in aspects of daily life and anxiety were identified in all treatment groups. Our data suggest that monotherapy or adjuvant therapy with venlafaxine is comparable to gabapentin for NeP management. We advocate for head-to-head, randomized, double-blinded studies of current NeP therapies.

Keywords: peripheral neuropathy, neuropathic pain, pharmacotherapy, venlafaxine, gabapentin

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

The importance of catastrophizing for successful pharmacological treatment of peripheral neuropathic pain

Toth C, Brady S, Hatfield M

Journal of Pain Research 2014, 7:327-338

Published Date: 24 June 2014

Readers of this article also read:

Nanoscale TiO2 nanotubes govern the biological behavior of human glioma and osteosarcoma cells

Tian A, Qin XF, Wu A, Zhang H, Xu Q, Xing D, Yang H, Qiu B, Xue X, Zhang D, Dong C

International Journal of Nanomedicine 2015, 10:2423-2439

Published Date: 25 March 2015

Inertial sensors as measurement tools of elbow range of motion in gerontology

Sacco G, Turpin JM, Marteu A, Sakarovitch C, Teboul B, Boscher L, Brocker P, Robert P, Guerin O

Clinical Interventions in Aging 2015, 10:491-497

Published Date: 23 February 2015

Nanomedicine strategies for treatment of secondary spinal cord injury

White-Schenk D, Shi R, Leary JF

International Journal of Nanomedicine 2015, 10:923-938

Published Date: 29 January 2015

Fluorescent magnetic iron oxide nanoparticles for cardiac precursor cell selection from stromal vascular fraction and optimization for magnetic resonance imaging

Verma VK, Kamaraju SR, Kancherla R, Kona LK, Beevi SS, Debnath T, Usha SP, Vadapalli R, Arbab AS, Chelluri LK

International Journal of Nanomedicine 2015, 10:711-726

Published Date: 20 January 2015

Managing comorbidities in COPD

Hillas G, Perlikos F, Tsiligianni I, Tzanakis N

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:95-109

Published Date: 7 January 2015

Optimal management of breast cancer in the elderly patient: current perspectives

Le Saux O, Ripamonti B, Bruyas A, Bonin O, Freyer G, Bonnefoy M, Falandry C

Clinical Interventions in Aging 2015, 10:157-174

Published Date: 6 January 2015

Management of corneal bee sting

Razmjoo H, Abtahi MA, Roomizadeh P, Mohammadi Z, Abtahi SH

Clinical Ophthalmology 2011, 5:1697-1700

Published Date: 2 December 2011

Management strategies for acne vulgaris

Whitney KM, Ditre CM

Clinical, Cosmetic and Investigational Dermatology 2011, 4:41-53

Published Date: 26 April 2011

Anesthetic management of spinal muscle atrophy type II in a parturient

Bollag L, Kent CD, Richebé P, Landau R

Local and Regional Anesthesia 2011, 4:15-20

Published Date: 6 April 2011